tiprankstipranks
Trending News
More News >
Structure Therapeutics, Inc. Sponsored ADR (GPCR)
:GPCR
US Market

Structure Therapeutics, Inc. Sponsored ADR (GPCR) Ownership - Who Owns Structure Therapeutics, Inc. Sponsored ADR?

Compare
1,004 Followers

Structure Therapeutics, Inc. Sponsored ADR (GPCR) Ownership Overview

11.67%32.60%43.64%0.96%11.13%
11.67% Insiders
43.64% Other Institutional Investors
0.96% ETFs
11.13% Public Companies and Individual Investors
The ownership structure of Structure Therapeutics, Inc. Sponsored ADR (GPCR) stock is a mix of institutional, retail, and individual investors. Approximately 77.20% of the company’s stock is owned by Institutional Investors, 11.67% is owned by Insiders, and 11.13% is owned by Public Companies and Individual Investors.
The ownership structure of Structure Therapeutics, Inc. Sponsored ADR (GPCR) stock is a mix of institutional, retail, and individual investors. Approximately 76.24% of the company’s stock is owned by Institutional Investors, 11.67% is owned by Insiders, and 0.96% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Mar 31, 2025
xxxxxxxxxxxxx
$73515
Mar 31, 2025
xxxxxxxxxxxxx
$206127
Mar 31, 2025
xxxxxxxxxxxxx
$521065
Mar 31, 2025
xxxxxxxxxxxxx
$3036589

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
4,249,142Institution7.39%92,121,399
3,800,961Institution6.61%82,404,834
2,847,885Insider4.95%61,742,147
2,688,264Insider4.67%58,281,564
1,517,418Institution2.64%32,897,622
1,484,467Institution2.58%32,183,245
1,458,288Institution2.53%31,615,684
1,272,743Institution2.21%27,593,068
1,022,281Institution1.78%22,163,052
929,176Institution1.61%20,144,536

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
4,249,142Institution7.39%92,121,399
3,800,961Institution6.61%82,404,834
1,484,467Institution2.58%32,183,245
1,458,288Institution2.53%31,615,684
1,022,281Institution1.78%22,163,052
929,176Institution1.61%20,144,536
740,102Institution1.29%16,045,411
678,434Institution1.18%14,708,449
582,447Institution1.01%12,627,451
387,466Institution0.67%8,400,263

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
230,932Institution0.40%5,006,606
54,928Institution0.10%1,220,500
41,336Institution0.07%715,526
40,743Institution0.07%883,308
37,765Institution0.07%839,138
28,208Institution0.05%626,782
22,880Institution0.04%508,394
16,641Institution0.03%449,307
15,000Institution0.03%585,063
6,859Institution0.01%152,407

FAQ

Who Owns Structure Therapeutics, Inc. Sponsored ADR (GPCR)?
According to the latest TipRanks data, approximately 43.64% of the company's stock is held by institutional investors, 11.67% is held by insiders, and 11.13% is held by retail investors.
    What percentage of Structure Therapeutics, Inc. Sponsored ADR (GPCR) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 43.64% of Structure Therapeutics, Inc. Sponsored ADR (GPCR) stock is held by institutional investors.
      What percentage of Structure Therapeutics, Inc. Sponsored ADR (GPCR) stock is held by retail investors?
      According to the latest TipRanks data, approximately 11.13% of Structure Therapeutics, Inc. Sponsored ADR (GPCR) stock is held by retail investors.
        Who owns the most shares of Structure Therapeutics, Inc. Sponsored ADR (GPCR)?
        VANGUARD SPECIALIZED FUNDS owns the most shares of Structure Therapeutics, Inc. Sponsored ADR (GPCR).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis